Evidence map›Paper›PMID 35197159›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022

Clinical standards for the diagnosis, treatment and prevention of TB infection.

G B Migliori, S J Wu, A Matteelli, D Zenner, D Goletti, S Ahmedov, S Al-Abri, D M Allen, M E Balcells, A L Garcia-Basteiro and 31 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 19 countries.

G B MiglioriRespiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
S J WuDivision of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore City.
A MatteelliDivision of Infectious and Tropical Diseases, Spedali Civili University Hospital, Brescia, Italy, WHO Collaborating Centre for TB/HIV Collaborative Activities and for TB Elimination Strategy, University of Brescia, Brescia, Italy.
D ZennerCentre for Global Public Health, Institute for Population Health Sciences, Queen Mary University, London, UK.
D GolettiTranslational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.
S AhmedovUSAID, Bureau for Global Health, TB Division, Washington, DC, USA.
S Al-AbriDirectorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman.
D M AllenDivision of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore City, Infectious Disease Translational Research Programme, Department of Medicine, National University of Singapore, Yong Loo Lin School of Medicine, Singapore City.
M E BalcellsDepartment of Infectious Diseases, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
A L Garcia-BasteiroCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique, ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
E CambauIAME UMR1137, INSERM, University of Paris, F-75018 Paris; AP-HP-Bichat Hospital, Associate laboratory of National Reference Center for Mycobacteria and Antimycobacterial Resistance, Paris, France.
R E ChaissonCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
C B E CheeTuberculosis Control Unit, Tan Tock Seng Hospital, Singapore, Singapore.
M P DalcolmoHelio Fraga Reference Center, Oswaldo Cruz Foundation Ministry of Health, Rio de Janeiro, Brazil.
J T DenholmVictorian Tuberculosis Program, Melbourne Health, Melbourne, VIC, Australia, Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
C ErkensKNCV Tuberculosis Foundation, The Hague, The Netherlands.
S EspositoPaediatric Clinic, Pietro Barilla Children´s Hospital, University of Parma, Parma, Italy.
P FarniaMycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J S FriedlandInstitute for Infection and Immunity, St George´s, University of London, London, UK.
S GrahamDepartment of Paediatrics, Center for International Child Health, University of Melbourne, Melbourne, VIC, Australia, Murdoch Children´s Research Institute, Royal Children´s Hospital, Melbourne, Australia.
Y HamadaInstitute for Global Health, University College London, London, UK.
A D HarriesInternational Union Against Tuberculosis and Lung Disease, Paris, France, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
A W KayThe Global Tuberculosis Program, Texas Children´s Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
A KritskiAcademic Tuberculosis Program Center, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
S MangaOperational Center, Medecins Sans Frontieres (MSF), Paris, France.
B J MaraisDepartment of Infectious Diseases and Microbiology, The Children´s Hospital at Westmead, Westmead, NSW, Australia, The University of Sydney Institute for Infectious Diseases, Sydney, NSW, Australia.
D MenziesMontréal Chest Institute, Montréal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montréal, QC, Canada, McGill International Tuberculosis Centre, Montréal, QC, Canada.
D NgInfectious Diseases, National Centre for Infectious Diseases, Singapore.
L PetroneTranslational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.
A RendonCentro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias CIPTIR, University Hospital of Monterrey UANL (Universidad Autonoma de Nuevo Leon), Monterrey, Mexico.
D R SilvaFaculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
H S SchaafDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
A SkrahinaRepublican Research and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus.
G SotgiuClinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
G ThwaitesOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
S TiberiDepartment of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK, Blizard Institute, Queen Mary University of London, London, UK.
N TukvadzeNational Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
J-P ZellwegerTB Competence Center, Swiss Lung Association, Berne, Switzerland.
L D AmbrosioPublic Health Consulting Group, Lugano, Switzerland.
R CentisRespiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
C W M OngDivision of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore City, Infectious Disease Translational Research Programme, Department of Medicine, National University of Singapore, Yong Loo Lin School of Medicine, Singapore City, National University of Singapore Institute for Health Innovation & Technology (iHealthtech), Singapore, Singapore.
Istituti Clinici Scientifici Maugeri · ITNational University Hospital · SGBarcelona Institute for Global Health · ESDesmond Tutu HIV Foundation · ZAInserm · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITJohns Hopkins University · USLondon School of Hygiene & Tropical Medicine · GBMasih Daneshvari Hospital · IRMcGill University Health Centre · CAMédecins Sans Frontières · FRMinistério da Saúde · BRMinistry of Health · OMNational Center for Tuberculosis and Lung Disease · GENational Centre for Infectious Diseases · SGNational University of Singapore · SGOxford University Clinical Research Unit · VNPontificia Universidad Católica de Chile · CLQueen Mary University of London · GB

Funding

Developing Clinical Prediction Tools to Define Strategies for Differentiated Service Delivery in Children and Adolescents Living with HIV in sub-Saharan Africa.K01TW011482 · FIC · BAYLOR COLLEGE OF MEDICINE · PI KAY, ALEXANDER WILLIAM · 2020 to 2024
$749k
FIC NIH HHS K01 TW011482
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Latent TuberculosisTuberculosisCaregiversChildHumansMass ScreeningReference Standards

Identifiers

PMID35197159
PMCPMC8886963
OpenAlexW4213415438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.